| Year |
Citation |
Score |
| 2017 |
Sill KN, Sullivan B, Carie A, Semple JE. Synthesis and Characterization of Micelle-Forming PEG-Poly(Amino Acid) Copolymers with Iron-Hydroxamate Cross-Linkable Blocks for Encapsulation and Release of Hydrophobic Drugs. Biomacromolecules. PMID 28475303 DOI: 10.1021/Acs.Biomac.7B00317 |
0.307 |
|
| 2017 |
Bakewell SJ, Carie A, Costich TL, Sethuraman J, Semple JE, Sullivan B, Martinez GV, Dominguez-Viqueira W, Sill KN. Imaging the Delivery of Drug-loaded, Iron-stabilized Micelles. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28115246 DOI: 10.1016/J.Nano.2017.01.009 |
0.42 |
|
| 2016 |
Carie A, Sullivan B, Ellis T, Semple JE, Buley T, Costich TL, Crouse R, Bakewell S, Sill K. Stabilized Polymer Micelles for the Development of IT-147, an Epothilone D Drug-Loaded Formulation. Journal of Drug Delivery. 2016: 8046739. PMID 28044108 DOI: 10.1155/2016/8046739 |
0.375 |
|
| 2016 |
Sethuraman J, Costich TL, Carie A, Buley T, Ellis T, Semple JE, Vojkovsky T, Sill K, Bakewell S. Abstract B22: IT-141, a stabilized polymer micelle formulation, prolongs the pharmacodynamic effect of SN-38 Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Cellcycle16-B22 |
0.468 |
|
| 2016 |
Sill K, Costich TL, Carie A, Sethuraman J, Buley T, Ellis T, Vojkovsky T, Sullivan B, Semple JE, Bakewell S. Abstract LB-190: IT-141 and IT-147, iron stabilized micellar nanoparticles for therapeutic and diagnostic applications Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-190 |
0.413 |
|
| 2016 |
Carie A, Buley T, Sullivan B, Semple JE, Ellis T, Costich TL, Sethuraman J, Crouse R, Sill K, Bakewell S. Abstract 1321: IT-147: A stabilized polymer micelle formulation of epothilone D for treatment of solid tumors Cancer Research. 76: 1321-1321. DOI: 10.1158/1538-7445.Am2016-1321 |
0.453 |
|
| 2016 |
Costich TL, Crouse R, Carie A, Buley T, Ellis T, Repp L, Semple JE, Vojkovsky T, Bakewell S, Sill K. Abstract 1317: IT-143: A nanoparticle delivery platform that encapsulates daunorubicin and widens therapeutic window Cancer Research. 76: 1317-1317. DOI: 10.1158/1538-7445.Am2016-1317 |
0.423 |
|
| 2013 |
Barkey NM, Preihs C, Cornnell HH, Martinez G, Carie A, Vagner J, Xu L, Lloyd MC, Lynch VM, Hruby VJ, Sessler JL, Sill KN, Gillies RJ, Morse DL. Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptor. Journal of Medicinal Chemistry. 56: 6330-8. PMID 23863078 DOI: 10.1021/Jm4005576 |
0.406 |
|
| 2012 |
Rios-Doria J, Carie A, Costich T, Burke B, Skaff H, Panicucci R, Sill K. A versatile polymer micelle drug delivery system for encapsulation and in vivo stabilization of hydrophobic anticancer drugs. Journal of Drug Delivery. 2012: 951741. PMID 22518317 DOI: 10.1155/2012/951741 |
0.398 |
|
| 2011 |
Carie A, Rios-Doria J, Costich T, Burke B, Slama R, Skaff H, Sill K. IT-141, a Polymer Micelle Encapsulating SN-38, Induces Tumor Regression in Multiple Colorectal Cancer Models. Journal of Drug Delivery. 2011: 869027. PMID 22187652 DOI: 10.1155/2011/869027 |
0.499 |
|
| 2011 |
Rios-Doria J, Costich TL, Carie A, Sill K. Abstract 4453: Development of a crosslinked, daunorubicin-loaded micelle with superior pharmacokinetics compared to free daunorubicin and with tunable stability Cancer Research. 71: 4453-4453. DOI: 10.1158/1538-7445.Am2011-4453 |
0.415 |
|
| 2010 |
Rios-Doria J, Carie A, Cardoen G, Sill K. Abstract 5489: The IVECT™ method, a versatile micelle for the delivery of chemotherapeutic drugs Cancer Research. 70: 5489-5489. DOI: 10.1158/1538-7445.Am10-5489 |
0.381 |
|
| 2010 |
Carie AE, Rios-Doria J, Cardoen G, Costich TL, Sill K. Abstract 3499: Nanoparticle formulation of SN-38 by the IVECT method results in a safer, more effective treatment for colorectal cancer Cancer Research. 70: 3499-3499. DOI: 10.1158/1538-7445.Am10-3499 |
0.468 |
|
| 2009 |
Kazi A, Carie A, Blaskovich MA, Bucher C, Thai V, Moulder S, Peng H, Carrico D, Pusateri E, Pledger WJ, Berndt N, Hamilton A, Sebti SM. Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy. Molecular and Cellular Biology. 29: 2254-63. PMID 19204084 DOI: 10.1128/Mcb.01029-08 |
0.515 |
|
| 2008 |
Kinkade R, Dasgupta P, Carie A, Pernazza D, Carless M, Pillai S, Lawrence N, Sebti SM, Chellappan S. A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Research. 68: 3810-8. PMID 18483265 DOI: 10.1158/0008-5472.Can-07-6672 |
0.574 |
|
| 2007 |
Carie AE, Sebti SM. A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene. 26: 3777-88. PMID 17260025 DOI: 10.1038/Sj.Onc.1210172 |
0.551 |
|
| 2006 |
Zhou H, Wang DA, Baldini L, Ennis E, Jain R, Carie A, Sebti SM, Hamilton AD. Structure-activity studies on a library of potent calix[4]arene-based PDGF antagonists that inhibit PDGF-stimulated PDGFR tyrosine phosphorylation. Organic & Biomolecular Chemistry. 4: 2376-86. PMID 16763682 DOI: 10.1039/B515483A |
0.555 |
|
| 2005 |
Sun J, Wang DA, Jain RK, Carie A, Paquette S, Ennis E, Blaskovich MA, Baldini L, Coppola D, Hamilton AD, Sebti SM. Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene. 24: 4701-9. PMID 15897913 DOI: 10.1038/Sj.Onc.1208391 |
0.517 |
|
| Show low-probability matches. |